Selected research
Industry Research
Drug Formulary Management Industry Research Report 2026
Market perspective
The global Drug Formulary Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Formulary Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Formulary Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Formulary Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Formulary Management include First Databank, Evernorth Health, Wolters Kluwer, McKesson, Salesforce, Pharmacy Purchasing & Products, VativoRx, Nuwae and MedReb8. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Formulary Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Formulary Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Formulary Management Market by Company
First Databank
Evernorth Health
Wolters Kluwer
McKesson
Salesforce
Pharmacy Purchasing & Products
VativoRx
Nuwae
MedReb8
Drug Formulary Management Segment by Type
Open Formulary
Closed Formulary
Drug Formulary Management Segment by Application
Hospital
Managed Care Organization (MCO)
Others
Drug Formulary Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Formulary Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Formulary Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Formulary Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Formulary Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Open Formulary
- Closed Formulary
Applications
- Hospital
- Managed Care Organization (MCO)
- Others
Companies covered
- First Databank
- Evernorth Health
- Wolters Kluwer
- McKesson
- Salesforce
- Pharmacy Purchasing & Products
- VativoRx
- Nuwae
- MedReb8
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Formulary Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Open Formulary
- 2.2.3 Closed Formulary
- 2.3 Drug Formulary Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Managed Care Organization (MCO)
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Drug Formulary Management Breakdown Data by Type
- 3.1 Global Drug Formulary Management Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Formulary Management Forecasted Market Size by Type (2027-2032)
4 Drug Formulary Management Breakdown Data by Application
- 4.1 Global Drug Formulary Management Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Formulary Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Formulary Management Market Perspective (2021-2032)
- 5.2 Global Drug Formulary Management Growth Trends by Region
- 5.2.1 Global Drug Formulary Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Formulary Management Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Formulary Management Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Formulary Management Market Dynamics
- 5.3.1 Drug Formulary Management Industry Trends
- 5.3.2 Drug Formulary Management Market Drivers
- 5.3.3 Drug Formulary Management Market Challenges
- 5.3.4 Drug Formulary Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Formulary Management Players by Revenue
- 6.1.1 Global Top Drug Formulary Management Players by Revenue (2021-2026)
- 6.1.2 Global Drug Formulary Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Formulary Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Formulary Management Head Office and Area Served
- 6.4 Global Drug Formulary Management Players, Product Type & Application
- 6.5 Global Drug Formulary Management Manufacturers Established Date
- 6.6 Global Drug Formulary Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Formulary Management Market Size (2021-2032)
- 7.2 North America Drug Formulary Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Formulary Management Market Size by Country (2021-2026)
- 7.4 North America Drug Formulary Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Formulary Management Market Size (2021-2032)
- 8.2 Europe Drug Formulary Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Formulary Management Market Size by Country (2021-2026)
- 8.4 Europe Drug Formulary Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Formulary Management Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Formulary Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Formulary Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Formulary Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Formulary Management Market Size (2021-2032)
- 10.2 South America Drug Formulary Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Formulary Management Market Size by Country (2021-2026)
- 10.4 South America Drug Formulary Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Formulary Management Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Formulary Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Formulary Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Formulary Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 First Databank
- 12.1.1 First Databank Company Information
- 12.1.2 First Databank Business Overview
- 12.1.3 First Databank Revenue in Drug Formulary Management Business (2021-2026)
- 12.1.4 First Databank Drug Formulary Management Product Portfolio
- 12.1.5 First Databank Recent Developments
- 12.2 Evernorth Health
- 12.2.1 Evernorth Health Company Information
- 12.2.2 Evernorth Health Business Overview
- 12.2.3 Evernorth Health Revenue in Drug Formulary Management Business (2021-2026)
- 12.2.4 Evernorth Health Drug Formulary Management Product Portfolio
- 12.2.5 Evernorth Health Recent Developments
- 12.3 Wolters Kluwer
- 12.3.1 Wolters Kluwer Company Information
- 12.3.2 Wolters Kluwer Business Overview
- 12.3.3 Wolters Kluwer Revenue in Drug Formulary Management Business (2021-2026)
- 12.3.4 Wolters Kluwer Drug Formulary Management Product Portfolio
- 12.3.5 Wolters Kluwer Recent Developments
- 12.4 McKesson
- 12.4.1 McKesson Company Information
- 12.4.2 McKesson Business Overview
- 12.4.3 McKesson Revenue in Drug Formulary Management Business (2021-2026)
- 12.4.4 McKesson Drug Formulary Management Product Portfolio
- 12.4.5 McKesson Recent Developments
- 12.5 Salesforce
- 12.5.1 Salesforce Company Information
- 12.5.2 Salesforce Business Overview
- 12.5.3 Salesforce Revenue in Drug Formulary Management Business (2021-2026)
- 12.5.4 Salesforce Drug Formulary Management Product Portfolio
- 12.5.5 Salesforce Recent Developments
- 12.6 Pharmacy Purchasing & Products
- 12.6.1 Pharmacy Purchasing & Products Company Information
- 12.6.2 Pharmacy Purchasing & Products Business Overview
- 12.6.3 Pharmacy Purchasing & Products Revenue in Drug Formulary Management Business (2021-2026)
- 12.6.4 Pharmacy Purchasing & Products Drug Formulary Management Product Portfolio
- 12.6.5 Pharmacy Purchasing & Products Recent Developments
- 12.7 VativoRx
- 12.7.1 VativoRx Company Information
- 12.7.2 VativoRx Business Overview
- 12.7.3 VativoRx Revenue in Drug Formulary Management Business (2021-2026)
- 12.7.4 VativoRx Drug Formulary Management Product Portfolio
- 12.7.5 VativoRx Recent Developments
- 12.8 Nuwae
- 12.8.1 Nuwae Company Information
- 12.8.2 Nuwae Business Overview
- 12.8.3 Nuwae Revenue in Drug Formulary Management Business (2021-2026)
- 12.8.4 Nuwae Drug Formulary Management Product Portfolio
- 12.8.5 Nuwae Recent Developments
- 12.9 MedReb8
- 12.9.1 MedReb8 Company Information
- 12.9.2 MedReb8 Business Overview
- 12.9.3 MedReb8 Revenue in Drug Formulary Management Business (2021-2026)
- 12.9.4 MedReb8 Drug Formulary Management Product Portfolio
- 12.9.5 MedReb8 Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst